• Medicine
  • 28 June
  • FDA to approve Arcutis' Zoryve cream
    2
  • FDA to approve Unicycive's Oxylanthanum carbonate
    2
  • 29 June
  • FDA to approve Viridian Therapeutics' Veligrotug
    2
  • 30 December
  • CDC to issue Level 4 warning by December 31
    2
  • FDA approves Retatrutide this year
    2
  • FDA to approve Daraxonrasib this year
    2
  • 31 December
  • When will the FDA move BPC-157 to Category 1
    4